Canakinumab for treatment of cryopyrin-associated periodic syndrome.
Feist, Eugen
Canakinumab for treatment of cryopyrin-associated periodic syndrome. [electronic resource] - Expert opinion on biological therapy Nov 2010 - 1631-6 p. digital
Publication Type: Journal Article; Research Support, Non-U.S. Gov't; Review
1744-7682
10.1517/14712598.2010.530653 doi
Acute-Phase Reaction
Adult
Antibodies, Monoclonal--adverse effects
Antibodies, Monoclonal, Humanized
Child
Child, Preschool
Clinical Trials, Phase II as Topic--statistics & numerical data
Cryopyrin-Associated Periodic Syndromes--epidemiology
Double-Blind Method
Humans
Inflammation
Interleukin-1beta--antagonists & inhibitors
Multicenter Studies as Topic--statistics & numerical data
Randomized Controlled Trials as Topic--statistics & numerical data
Treatment Outcome
Canakinumab for treatment of cryopyrin-associated periodic syndrome. [electronic resource] - Expert opinion on biological therapy Nov 2010 - 1631-6 p. digital
Publication Type: Journal Article; Research Support, Non-U.S. Gov't; Review
1744-7682
10.1517/14712598.2010.530653 doi
Acute-Phase Reaction
Adult
Antibodies, Monoclonal--adverse effects
Antibodies, Monoclonal, Humanized
Child
Child, Preschool
Clinical Trials, Phase II as Topic--statistics & numerical data
Cryopyrin-Associated Periodic Syndromes--epidemiology
Double-Blind Method
Humans
Inflammation
Interleukin-1beta--antagonists & inhibitors
Multicenter Studies as Topic--statistics & numerical data
Randomized Controlled Trials as Topic--statistics & numerical data
Treatment Outcome